Diabetes News

Endocrinology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Björklund P et al. - In a study to assess the use of stathmin as a marker for malignancy in pheochromocytomas, stathmin protein overexpression was observed by immunohistochemistry, and distinct differential protein expression between benign and malignant/metastasis specimens was confirmed by Western blot analysis. The results introduce stathmin as a possible diagnostic marker for malignant pheochromocytomas.

Methods

Results

Related Articles

Clinical Predictors and Algorithm for the Genetic Diagnosis of Pheochromocytoma Patients
Clinical Cancer Research, 10/19/09    Relevance Score: 87%

ACTH-producing pheochromocytoma: Clinical considerations and concise review of the literature
European Journal of Internal Medicine, 10/12/09    Relevance Score: 85%

Radiofrequency Ablation of Metastatic Pheochromocytoma
Journal of Vascular and Interventional Radiology, 11/13/09    Relevance Score: 83%

Comparison of 18F-Fluoro-L-DOPA, 18F-Fluoro-Deoxyglucose, and 18F-Fluorodopamine PET and 123I-MIBG Scintigraphy in the Localization of Pheochromocytoma and Paraganglioma
Journal of Clinical Endocrinology and Metabolism, 11/12/09    Relevance Score: 82%

Unusual Presentation of Pheochromocytoma with Ischemic Sigmoid Colitis and Stenosis
Southern Medical Journal, 10/08/09    Relevance Score: 82%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address